Status: Recruiting
A Study of MZE782 in Adults With PKU
The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).
Participants needed: 38
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Maze TherapeuticsUpdated: Aug 20, 2026Locations: 6
Eligibility criteria
Males and females 18 to 75 years old [+5]
Is pregnant, breastfeeding, or planning to become pregnant or conceive a child d... [+3]